DrugPatentWatch Database Preview
NUTRESTORE Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Nutrestore, and when can generic versions of Nutrestore launch?
The generic ingredient in NUTRESTORE is l-glutamine. There are forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the l-glutamine profile page.
Summary for NUTRESTORE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 113 |
| Clinical Trials: | 11 |
| Patent Applications: | 194 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NUTRESTORE at DailyMed |
Pharmacology for NUTRESTORE
| Ingredient-type | Amino Acids |
| Drug Class | Amino Acid |
Synonyms for NUTRESTORE
| .gamma.-Glutamine |
| (2S)-2-amino-4-carbamoylbutanoate |
| (2S)-2-amino-4-carbamoylbutanoic acid |
| (2S)-2,5-diamino-5-oxo-pentanoic acid |
| (2S)-2,5-diamino-5-oxopentanoic acid |
| (3S)-3-AMINO-1-CARBAMOYL-3-CARBOXYPROPYL |
| (S)-2-Amino-4-carbamoyl-butyric acid |
| (S)-2,5-Diamino-5-oxopentanoate |
| (S)-2,5-Diamino-5-oxopentanoic acid |
| (S)-2,5-Diamino-5-oxopentanoic acid; L-Glutamic acid 5-amide |
| (S)-glutamine |
| [14C]-glutamine |
| [14C]glutamine |
| [3H]-glutamine |
| [3H]glutamine |
| 008G044 |
| 0RH81L854J |
| 141066-EP2269996A1 |
| 141066-EP2292625A1 |
| 16575-EP2269996A1 |
| 16575-EP2270004A1 |
| 16575-EP2275412A1 |
| 16575-EP2277861A1 |
| 16575-EP2277876A1 |
| 16575-EP2281563A1 |
| 16575-EP2281815A1 |
| 16575-EP2281824A1 |
| 16575-EP2284157A1 |
| 16575-EP2284171A1 |
| 16575-EP2286812A1 |
| 16575-EP2289876A1 |
| 16575-EP2289883A1 |
| 16575-EP2289892A1 |
| 16575-EP2289893A1 |
| 16575-EP2292611A1 |
| 16575-EP2292614A1 |
| 16575-EP2295055A2 |
| 16575-EP2295401A2 |
| 16575-EP2295411A1 |
| 16575-EP2295416A2 |
| 16575-EP2295417A1 |
| 16575-EP2295429A1 |
| 16575-EP2298312A1 |
| 16575-EP2298748A2 |
| 16575-EP2298780A1 |
| 16575-EP2301533A1 |
| 16575-EP2301940A1 |
| 16575-EP2302382A2 |
| 16575-EP2302383A2 |
| 16575-EP2305640A2 |
| 16575-EP2305652A2 |
| 16575-EP2305663A1 |
| 16575-EP2305688A1 |
| 16575-EP2305689A1 |
| 16575-EP2305695A2 |
| 16575-EP2305696A2 |
| 16575-EP2305697A2 |
| 16575-EP2305698A2 |
| 16575-EP2308844A2 |
| 16575-EP2308845A2 |
| 16575-EP2308846A2 |
| 16575-EP2311453A1 |
| 16575-EP2311806A2 |
| 16575-EP2316459A1 |
| 1wdn |
| 2-aminoglutaramic acid |
| 2-Aminoglutaramic acid, L- |
| 2,5-Diamino-5-oxopentanoic acid, (S)- |
| 26700-71-0 |
| 29474-EP2272827A1 |
| 29474-EP2277867A2 |
| 29474-EP2280003A2 |
| 29474-EP2292088A1 |
| 29474-EP2292611A1 |
| 29474-EP2295410A1 |
| 29474-EP2301939A1 |
| 29474-EP2311842A2 |
| 32640-56-5 |
| 3h-l-glutamine |
| 4-04-00-03038 (Beilstein Handbook Reference) |
| 56-85-9 |
| 7FBA778C-D6B8-495C-BFE7-1CB8EC4ABEAB |
| AB0004431 |
| AB00173347_04 |
| AB00173347-03 |
| AB1002635 |
| AC1L1LI9 |
| AC1Q4U8A |
| AC1Q5J69 |
| AES-14 |
| Aesgen-14 |
| AI3-24392 |
| AJ-26776 |
| AK-81265 |
| AKOS015854078 |
| AM003938 |
| AM027431 |
| AM81759 |
| AmbotzHAA1083 |
| ANW-32592 |
| AS-11765 |
| BDBM18121 |
| bmse000038 |
| bmse001014 |
| BP-13284 |
| BRD-K83896451-001-01-8 |
| BRN 1723797 |
| BSPBio_003092 |
| BT000151 |
| C00064 |
| CCG-38853 |
| CCRIS 9428 |
| Cebrogen |
| Cebrogen, Stimulina |
| CHEBI:18050 |
| CHEMBL930 |
| CS-1947 |
| CTK1G9994 |
| D00015 |
| D01JIA |
| DB00130 |
| DivK1c_006476 |
| DTXSID1023100 |
| E-6014 |
| Earthlink Science Glutamine Chews Chocolate (Amerifit) |
| EBD968977 |
| EINECS 200-292-1 |
| EU-0100549 |
| F0001-1471 |
| FEMA No. 3684 |
| FT-0627836 |
| G 3126 |
| G0063 |
| gamma-Glutamine |
| Glavamin |
| gln |
| glumin |
| Glumin (amino acid) |
| glutamic acid 5-amide |
| Glutamic acid amide |
| glutamine |
| GLUTAMINE (D) |
| Glutamine (INN) |
| Glutamine (L-Glutamine) |
| GLUTAMINE (L) |
| Glutamine (USP) |
| Glutamine (VAN) |
| Glutamine [USAN] |
| Glutamine [USP] |
| Glutamine Express (Genetic Evolutionary Nutrition) |
| Glutamine Fuel Mega (Twinlab) |
| Glutamine Fuel Powder (Twinlab) |
| Glutamine-S |
| GLUTAMINE, L- |
| Glutamine, United States Pharmacopeia (USP) Reference Standard |
| GTPL4633 |
| GTPL4634 |
| GTPL723 |
| H-Gln |
| H-Gln-OH |
| HMS3261N19 |
| HMS3264C03 |
| HY-N0390 |
| I14-2733 |
| J-521645 |
| KB-53212 |
| KB-77550 |
| KBio1_001420 |
| KBio2_000591 |
| KBio2_003159 |
| KBio2_005727 |
| KBio3_002312 |
| KBioGR_002038 |
| KBioSS_000591 |
| KS-00000AA5 |
| KS-000010SX |
| KSC269S9J |
| L-(+)-Glutamine |
| L-[3,4-3H(N)]glutamine |
| L-2-Aminoglutaramic acid |
| L-2-Aminoglutaramidic acid |
| L-Alanyl-L-glutamide |
| L-gln |
| L-Glutamic acid .gamma.-amide |
| L-Glutamic acid 5-amide |
| L-Glutamic acid gamma-amide |
| L-Glutamid |
| L-Glutamide |
| L-Glutamin |
| L-glutamine |
| L-Glutamine (JP17) |
| L-glutamine (oral, short bowel syndrome), Emmaus |
| L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus |
| L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles |
| L-glutamine (topical, chemotherapy-induced mucositis), Aesgen |
| L-Glutamine [JAN] |
| L-Glutamine Powder |
| L-Glutamine Power (Champion Nutrition) |
| L-Glutamine Solution 200 mM, 29.23 mg/mL in saline, solution, suitable for cell culture |
| L-Glutamine solution, 200 mM, Hybri-Max(TM), sterile-filtered, suitable for hybridoma |
| L-Glutamine solution, 200 mM, solution, sterile-filtered, BioXtra, suitable for cell culture |
| L-Glutamine, 98.5% |
| L-Glutamine, 99% 50g |
| L-Glutamine, BioUltra, >=99.5% (NT) |
| L-Glutamine, Cell Culture Reagent |
| L-Glutamine, certified reference material, TraceCERT(R) |
| L-Glutamine, gamma-irradiated, BioXtra, suitable for cell culture |
| L-Glutamine, homopolymer |
| L-Glutamine, meets USP testing specifications, cell culture tested, 99.0-101.0%, from non-animal source |
| L-Glutamine, pharmaceutical secondary standard; traceable to USP |
| L-Glutamine, PharmaGrade, Ajinomoto, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture |
| L-Glutamine, ReagentPlus(R), >=99% (HPLC) |
| L-Glutamine, SAJ special grade, >=99.0% |
| L-Glutamine, Vetec(TM) reagent grade, >=99% |
| L-Glutaminsaeure-5-amid |
| L-Glutaminsaure-5-amid |
| laevo-glutamine |
| Levoglutamid |
| Levoglutamida |
| Levoglutamida [INN-Spanish] |
| Levoglutamide |
| Levoglutamide [DCF:INN] |
| Levoglutamidum |
| Levoglutamidum [INN-Latin] |
| Levoglutamina |
| Lopac0_000549 |
| LP00549 |
| LS-71898 |
| M02960 |
| MCULE-8718820108 |
| MFCD00008044 |
| Miglu-P |
| MolPort-001-794-053 |
| N-(2)-L-alanyl-L-glutamine |
| NCGC00093936-01 |
| NCGC00093936-02 |
| NCGC00093936-03 |
| NCGC00093936-04 |
| NCGC00093936-05 |
| NCGC00261234-01 |
| NE10548 |
| NSC 27421 |
| NSC-759628 |
| NSC-760081 |
| NSC759628 |
| NSC760081 |
| Nutrestore (TN) |
| Pentanoic acid, 2,5-diamino-5-oxo-, (S)- |
| Pharmakon1600-01300018 |
| Pharmakon1600-01500987 |
| Poly(glutamine) |
| Polyglutamine |
| Proteinogene aminos?uren und stereoisomer D-formen und ihre salze mit gegenionen der WGK 1 |
| Q-100459 |
| RP21049 |
| RTC-066534 |
| S(+)-Glutamic acid 5-amide |
| S(+)Glutamine |
| s1749 |
| Saforis |
| SBI-0050532.P003 |
| SCHEMBL19240116 |
| SCHEMBL7453 |
| SDCCGMLS-0066691.P001 |
| SPBio_001334 |
| SpecPlus_000380 |
| Spectrum_000131 |
| SPECTRUM1500987 |
| Spectrum2_001377 |
| Spectrum3_001416 |
| Spectrum4_001709 |
| Spectrum5_000418 |
| ST2407066 |
| Stimulina |
| TC-066534 |
| Tox21_500549 |
| UNII-0RH81L854J |
| UNII-5L555N1902 component ZDXPYRJPNDTMRX-VKHMYHEASA-N |
| Z1250208676 |
| ZDXPYRJPNDTMRX-VKHMYHEASA-N |
| ZINC1532526 |
US Patents and Regulatory Information for NUTRESTORE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emmaus Medcl | NUTRESTORE | l-glutamine | FOR SOLUTION;ORAL | 021667-001 | Jun 10, 2004 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for NUTRESTORE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emmaus Medcl | NUTRESTORE | l-glutamine | FOR SOLUTION;ORAL | 021667-001 | Jun 10, 2004 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
see a sample report or, see our see our flat-rate plans
